MedPath

Quantification of metabolism (F-18-Deoxyglucose) and bone turnover (F-18-Fluoride) using positron emission tomography and computed tomography (PET/CT) in patients with multiple myeloma and osteoporosis (B9-SFB-TR79)

Conditions
C90
M82
Multiple myeloma and malignant plasma cell neoplasms
Osteoporosis in diseases classified elsewhere
Registration Number
DRKS00000321
Lead Sponsor
Deutsches Krebsforschungszentrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients with confirmed multiple myeloma prior treatment, following chemotherapy, after kyphoplasty, as well as patients with osteoporosis

Exclusion Criteria

rejection by the patient; diabetes mellitus; acute psychosis and other cases of limited understanding of the procedure; pregnancy; claustrophobic patients; patients younger than 18 years;

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
dPET-CT prior to chemotherapy and kyphoplasty. Obtaining basic data about metabolism and bone turnover prior to treatment.
Secondary Outcome Measures
NameTimeMethod
dPET-CT following chemotherapy and kyphoplasty. Achieving follow up data about metabolism and bone turnover after treatment.
© Copyright 2025. All Rights Reserved by MedPath